Astera Labs (NASDAQ:ALAB) Shares Gap Up – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) gapped up before the market opened on Tuesday . The stock had previously closed at $165.19, but opened at $172.31. Astera Labs shares last traded at $178.2080, with a volume of 1,541,747 shares.

Analyst Ratings Changes

A number of brokerages have weighed in on ALAB. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, October 8th. Roth Capital upped their price objective on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Northland Capmk upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 17th. Evercore ISI boosted their target price on Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 6th. Finally, JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average target price of $187.06.

Astera Labs Price Performance

The company has a fifty day moving average price of $171.71 and a two-hundred day moving average price of $150.21. The company has a market capitalization of $25.76 billion, a P/E ratio of 137.40, a PEG ratio of 2.66 and a beta of 1.51.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same quarter last year, the business earned $0.23 EPS. The firm’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total value of $1,921,600.00. Following the sale, the general counsel owned 151,573 shares of the company’s stock, valued at $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 586,936 shares of company stock valued at $89,331,140 in the last quarter. Insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Clearstead Advisors LLC grew its stake in Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after acquiring an additional 76 shares during the period. Great Valley Advisor Group Inc. raised its position in shares of Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares during the period. Straight Path Wealth Management lifted its holdings in shares of Astera Labs by 1.5% in the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after purchasing an additional 100 shares in the last quarter. Rye Brook Capital LLC lifted its holdings in shares of Astera Labs by 1.1% in the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares in the last quarter. Finally, Assetmark Inc. grew its position in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. 60.47% of the stock is owned by institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.